Dermatology
FDA approves MERREM I.V. for complicated skin and skin structure infections
Published in Medical Letter on the CDC and FDA, June 26th, 2005
MERREM currently is indicated and approved for use in the United States as a single-agent therapy for intra-abdominal infections and bacterial meningitis.
The approval is based on results from one of the largest studies conducted to date of hospitalized patients with cSSSI. The study showed that MERREM, administered 500 mg IV every 8 hours, is a well-tolerated and effective treatment for patients with cSSSI, including the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax Therapy
Management of anthrax meningitis reviewed - Heart Disease Risk Factors
Moderate drinking may not reduce cardiovascular disease risk - Human Papillomavirus
Factors linked to cervical cancer in HPV-16-positive women reported - Obesity Therapy
Diet and physical activity surveyed among Americans trying to lose weight - Obstetrics
Pregnancy-related mortality in United States assessed - Addiction Medicine
Over 4% of pregnant women used illicit drugs in past month - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
